Erratum: α6β4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-κB-dependent resistance to apoptosis in 3D mammary acini (J. Cell Sci. (2007) 120 (3700-3712) DOI: 10.1242/jcs.03484);α6β4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-κB-dependent resistance to apoptosis in 3D mammary acini

Journal of Cell Science

Volumn 120, Issue 20, 2007, Pages 3700-3712

  Friedland, Julie C ^a,b   Lakins, Johnathon N ^a,b,c   Kazanietz, Marcelo G ^a   Chernoff, Jonathan ^d   Boettinger, David ^a   Weaver, Valerie M ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d FOX CHASE CANCER CENTER   (United States)

Author keywords

Apoptosis resistance; Mammary epithelial cells; NF B; Pak1; Rac; 6 4 integrin

Indexed keywords

ALPHA6BETA4 INTEGRIN; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; P21 ACTIVATED KINASE 1; RAC PROTEIN; P21 ACTIVATED KINASE; PAK1 PROTEIN, HUMAN; PROTEIN KINASE B; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ACINAR CELL; APOPTOSIS; ARTICLE; BREAST CELL; BREAST TUMOR; CELL MEMBRANE RESISTANCE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SUBUNIT; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; STROMA; TISSUE SPECIFICITY; WILD TYPE; CYTOLOGY; MAMMARY GLAND; METABOLISM; PHYSIOLOGY;

APOPTOSIS; ENZYME ACTIVATION; HUMANS; INTEGRIN ALPHA6BETA4; MAMMARY GLANDS, HUMAN; P21-ACTIVATED KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RAC GTP-BINDING PROTEINS; TRANSCRIPTION FACTOR RELA;

EID: 36248998112     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.261623     Document Type: Erratum

References (97)

1. Akhtar, N. and Streuli, C. H. (2006). Racl links integrin-mediated adhesion to the control of lactational differentiation in mammary epithelia. J. Cell Biol. 173, 781-793.
2. Alahari, S. K. (2003). Nischarin inhibits Rac induced migration and invasion of epithehial cells by affecting signaling cascades involving PAK. Exp. Cell Res. 288, 415-424.
3. Alahari, S. K., Reddig, P. J. and Juliano, R. L. (2004). The integrin-binding protein Nischarin regulates cell migration by inhibiting PAK. EMBO J. 23, 2777-2788.
4. Bachelder, R. E., Ribick, M. J., Marchetti, A., Falcioni, R., Soddu, S., Davis, K. R. and Mercurio, A. M. (1999). p53 inhibits alpha 6 beta 4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKB. J. Cell Biol. 147, 1063-1072.
5. Baeuerle, P. A. and Baltimore, D.(1996). NF-kappa B: ten years after. Cell 87, 13-20.
6. Baldwin, A. S. (2001). Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J. Clin. Invest. 107, 241-246.
7. Barros, E. J., Santos, O. F., Matsumoto, K., Nakamura, T. and Nigam, S. K. (1995). Differential tubulogenic and branching morphogenetic activities of growth factors: implications for epithelial tissue development. Proc. Natl. Acad Sci. USA 92, 4412-4416.
8. Bates, R. C., Buret, A., van Helden, D. F., Horton, M. A. and Burns, G. F. (1994). Apoptosis induced by inhibition of intercellular contact. J. Cell Biol. 125, 403-415.
9. Beeser, A., Jaffer, Z. M., Hofmann, C. and Chernoff, J. (2005). Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors. J. Biol. Chem. 280, 36609-36615.
10. Bershadsky, A. D., Ballestrem, C., Carramusa, L., Zilberman, Y., Gilquin, B., Khochbin, S., Alexandrova, A. Y., Verkhovsky, A. B., Shemesh, T. and Kozlov, M. M. (2006). Assembly and mechanosensory function of focal adhesions: experiments and models. Eur J. Cell Biol. 85, 165-173.
11. Bissell, M. J. and Radisky, D. (2001). Putting tumours in context. Nat. Rev. Cancer 1, 46-54.
12. Boettner, B. and Van Aelst, L. (1999). Rac and Cdc42 effectors. Prog. Mol. Subcell. Biol. 22, 135-158.
13. Bokoch, G. M. (2003). Biology of the p2l-activated kinases. Annu. Rev. Biochem. 72, 743-781.
14. Bouzahzah, B., Albanese, C., Ahmed, F., Pixley, F., Lisanti, M. F., Segall, J. D., Condeelis, J., Joyce, D., Minden, A., Der, C. J. et al.(2001). Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol. Med. 7, 816-830.
15. Boxer, R. B., Stairs, D. B., Dugan, K. D., Notarfrancesco, K. L., Portocarrero, C. P., Keister, B. A., Belka, G. K., Cho, H., Rathmell, J. C., Thompson, C. B. et al. (2006). Isoform-specific requirement for Akt1 in the developmental regulation of cellular metabolism during lactation. Cell Metab. 4, 475-490.
16. Brown, M. C., Cary, L. A., Jamieson, J. S., Cooper, J. A. and Turner, C. E. (2005). Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusiveness. Mol. Biol. Cell 16, 4316-4328.
17. Caloca, M. J., Wang, H. and Kazanietz, M. G. (2003). Characterization of the Rac-GAP (Rac-GTPase-activating protein) activity of beta2-chimaerin, a 'non-protein kinase C'phorbol ester receptor. Biochem. J. 375, 313-321.
18. Cammarano, M. S. and Minden, A. (2001). Db1 and the Rho GTPases activate NF kappaB by I kappaB kinase (IKK)-dependent and IKK-independent pathways. J. Biol. Chem. 276, 25876-25882.
19. Chan, A. Y., Coniglio, S. I., Chuang, Y. Y., Michaelson, D., Knaus, U. G., Philips, M. R. and Symons, M. (2005). Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene 24, 7821-7829.
20. Chen, X. and Macara, L. G.(2005). Par-3 controls tight junction assembly through the Rac exchange factor Tiam1. Nat. Cell Biol. 7, 262-269.
21. Coniglio, S. J., Jon, T. S. and Symons, M. (2001). Rac1 protects epithelial cells against anoikis. J. Biol. Chem. 276, 28113-28120.
22. Cotteret, S., Jaffer, Z. M., Beeser, A. and Chernoff, J.(2003). p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD. Mol. Cell. Biol. 23, 5526-5539.
23. Dadke, D., Fryer, B. H., Golemis, E. A. and Field, J. (2003). Activation of p2l-activated kinase 1 -nuclear factor kappaB signaling by Kaposi's sarcoma-associated herpes virus G protein-coupled receptor during cellular transformation. Cancer Res. 63, 8837-8847.
24. Dalton, W. S. (2003). The tumor microenvironment: focus on myeloma. Cancer Treat. Rev. 29 Suppl. 1, 11-19.
25. Damiano, J. S., Cress, A. E., Hazlehurst, L. A., Shtil, A. A. and Dalton, W. S. (1999). Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood 93, 1658-1667.
26. Davis, T. L., Cress, A. E., Dalkin, B. L. and Nagle, R. B. (2001). Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma. Prostate 46, 240-248.
27. Deacon, K., Mistry, P., Chernoff, J., Blank, J. L. and Patel, R. (2003). p38 Mitogen-activated protein kinase mediates cell death and p2l-activated kinase mediates cell survival during chemotherapeutic drug-induced mitotic arrest. Mol. Biol. Cell 14, 2071-2087.
28. Debnath, J., Muthuswamy, S. K. and Brugge, J. S. (2003). Morphogenesis and oncogenesis of MCF-IOA mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256-268.
29. Desoize, B. and Jardillier, J. (2000). Multicellular resistance: a paradigm for clinical resistance? Crit. Rev. Oncol. Hematol. 36, 193-207.
30. Durand, R. E. and Olive, P. L. (2001). Resistance of tumor cells to chemo- and radiotherapy modulated by the three-dimensional architecture of solid tumors and spheroids. Methods Cell Biol. 64, 211-233.
31. Engler, A. J., Sen, S., Sweeney, H. L. and Discher, D. E. (2006). Matrix elasticity directs stem cell lineage specification. Cell 126, 677-689.
32. Fernandez, Y., Gu, B., Martinez, A., Torregrosa, A. and Sierra, A. (2002). Inhibition of apoptosis in human breast cancer cells: role in tumor progression to the metastatic state. Int. J. Cancer 101, 317-326.
33. Fritz, G., Just, I. and Kaina, B. (1999). Rho GTPases are over-expressed in human tumors. Int. J. Cancer 81, 682-687.
34. Frost, J. A., Swantek, J. L., Stippec, S., Yin, M. J., Gaynor, R. and Cobb, M. H. (2000). Stimulation of NFkappaB activity by multiple signaling pathways requires PAK1. J. Biol. Chem. 275, 19693-19699.
35. Fulda, S. and Debatin, K. M. (2004). Apoptosis signaling in tumor therapy. Ann. N. Y. Acad Sci. 1028, 150-156.
36. Gnesutta, N., Qu, J. and Minden, A. (2001). The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J. Biol. Chem. 276, 14414-14419.
37. Gupta, G. P. and Massague, J. (2006). Cancer metastasis: building a framework. Cell 127, 679-695.
38. He, T. C., Zhou, S., da Costa, L. T., Ya, J., Kinzler, K. W. and Vogelstein, B. (1998). A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95, 2509-2514.
39. Hermiston, M. L. and Gordon, J. L. (1995). In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. J. Cell Biol. 129, 489-506.
40. Hutchinson, J. N., Jin, J., Cardiff, R. D., Woodgett, J. R. and Muller, W. J. (2004). Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res. 64, 3171-3178.
41. Igney, F. H. and Krammer, P. H. (2002). Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2, 277-288.
42. Irie, H. Y., Pearline, R. V., Grueneberg, D., Hsia, M., Ravichandran, P., Kothari, N., Natesan, S. and Brugge, J. S. (2005). Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J. Cell Biol. 171, 1023-1034.
43. Jacquier, A., Bubler, E., Schafer, M. K., Bohl, D., Blanchard, S., Beclin, C. and Haase, G. (2006). Alsin/Racl signaling controls survival and growth of spinal motoneurons. Ann. Neurol. 60, 105-117.
44. Jain, R. K. (1987). Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 6, 559-593.
45. Johnson, K. and D'Mello, S. R. (2005). p21-Activated kinase-1 is necessary for depolarization-mediated neuronal survival. J. Neurosci. Res 79, 809-815.
46. Johnson, K. R., Leight, J. L. and Weaver, V. M. (2007). Demystifying the effects of a three-dimensional microenvironment in tissue morphogenesis. Methods Cell Biol. 83, 547-583.
47. Jones, J. L., Royall, J. E., Critchley, D. R. and Walker, R. A. (1997). Modulation of myoepithelial-associated alpha6beta4 integrin in a breast cancer cell line alters invasive potential. Exp. Cell Res. 235, 325-333.
48. Ju, X., Katiyar, S., Wang, C., Liu, M., Jiao, X., Li, S., Zhou, J., Turner, J., Lisanti, M. P., Russell, R. G. et al. (2007). Akt1 governs breast cancer progression in vivo. Proc. Natl. Acad. Sci. USA 104, 7438-7443.
49. Kerbel, R. S. (1994). Impact of multicellular resistance on the survival of solid tumors, including micrometastases. Invasion Metastasis 14, 50-60.
50. Kerbel, R. S., St Croix, B., Florenes, V. A. and Rak, J. (1996). Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors. Hum. Cell 9, 257-264.
51. Kim, D. W., Sovak, M. A., Zanieski, G., Nonet, G., Romieu-Mourez, R., Lau, A. W., Hafer, L. J., Yaswen, P., Stampfer, M., Rogers, A. E. et al. (2000). Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis 21, 871-879.
52. Kirshner, J., Chen, C. J., Liu, P., Huang, J. and Shively, J. E. (2003). CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture. Proc. Natl. Acad. Sci. USA 100, 521-526.
53. Kuh, H. J., Jang, S. H., Wientjes, M. G., Weaver, J. R. and An, J. L. (1999). Determinants of paclitaxel penetration and accumulation in human solid tumor. J. Pharmacol. Exp. Ther. 290, 871-880.
54. Lipscomb, E. A. and Mercurio, A. M. (2005). Mobilization and activation of a signaling competent alpha6beta4integrin underlies its contribution to carcinoma progression. Cancer Metastasis Rev. 24, 413-423.
55. Lipscomb, E. A., Simpson, K. J., Lyle, S. R., Ring, J. E., Dugan, A. S. and Mercurio, A. M. (2005). The alpha6beta4 integrin maintains the survival of human breast carcinoma cells in vivo. Cancer Res. 65, 10970-10976.
56. Martin-Belmonte, F., Gassama, A., Datta, A., Yu, W., Rescher, U., Gerke, V. and Mostov, K. (2007). PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell 128, 383-397.
57. Matter, M. L. and Ruoslahti, E. (2001). A signaling pathway from the alpha5beta1 and alpha(v)beta3 integrins that elevates bcl-2 transcription. J. Biol. Chem. 276, 27757-27763.
58. McBeath, R., Pirone, D. M., Nelson, C. M., Bhadriraju, K. and Chen, C. S. (2004). Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev. Cell 6, 483-495.
59. Menard, R. E., Jovanovski, A. P. and Mattingly, R. R. (2005). Active p21-activated kinase 1 rescues MCF10A breast epithelial cells from undergoing anoikis. Neoplasia 7, 638-645.
60. Mercurio, A. M. and Rabinovitz, I. (2001). Towards a mechanistic understanding of tumor invasion - lessons from the alpha6beta 4 integrin. Semin. Cancer Biol. 11, 129-141.
61. Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., Jr and Sledge, G. W., Jr (1997). Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17, 3629-3639.
62. Narita, T., Kimura, N., Sato, M., Matsuura, N. and Kannagi, R. (1998). Altered expression of integrins in adriamycin-resistant human breast cancer cells. Anticancer Res. 18, 257-262.
63. O'Brien, L. E., Jou, T. S., Pollack, A. L., Zhang, Q., Hansen, S. H., Yurchenco, P. and Mostov, K. E. (2001). Rac1 orientates epithelial apical polarity through effects on basolateral laminin assembly. Nat. Cell Biol. 3, 831-838.
64. Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D. et al. (2005). Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241-254.
65. Plas, D. R. and Thompson, C. B. (2002). Cell metabolism in the regulation of programmed cell death. Trends Endocrinol. Metab. 13, 75-78.
66. Puto, L. A., Pestonjamasp, K., King, C. C. and Bokoch, G. M. (2003). p21-activated kinase 1 (PAKI) interacts with the Grb2 adapter protein to couple to growth factor signaling. J. Biol. Chem. 278, 9388-9393.
67. Qu, J., Cammarano, M. S., Shi, Q., Ha, K. C., de Lanerolle, P. and Minden, A. (2001). Activated PAK4 regulates cell adhesion and anchorage-independent growth. Mol. Cell. Biol. 21, 3523-3533.
68. Russell, A. J., Fincher, E. F., Millman, L., Smith, R., Vela, V., Waterman, E. A., Dey, C. N., Guide, S., Weaver, V. M. and Marinkovich, M. P. (2003). Alpha 6 beta 4 integrin regulates keratinocyte chemotaxis through differential GTPase activation and antagonism of alpha 3 beta 1 integrin. J. Cell Sci. 116, 3543-3556.
69. Santini, M. T., Rainaldi, G. and Indovina, P. L. (2000). Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. Crit. Rev. Oncol. Hematol. 36, 75-87.
70. Schmitz, A. A., Govek, E. E., Bottner, B. and Van Aelst, L. (2000). Rho GTPases: signaling, migration, and invasion. Exp. Cell Res. 261, 1-12.
71. Schurmann, A., Mooney, A. E, Sanders, L. C., Sells, M. A., Wang, H. G., Reed, J. C. and Bokoch, G. M. (2000). p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis. Mol. Cell. Biol. 20, 453-461.
72. Sethi, T., Rintoul, R. C., Moore, S. M., MacKinnon, A. C., Salter, D., Choo, C., Chilvers, E. R., Dransfield, I., Donnelly, S. C., Strieter, R. et al. (1999). Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat. Med. 5, 662-668.
73. Shaw, L. M., Rabinovitz, I., Wang, H. H., Toker, A. and Mercurio, A. M. (1997). Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinorna invasion. Cell 91, 949-960.
74. Sminia, P., Acker, H., Eikesdal, H. P., Kaaijk, P., Enger, P., Slotman, B. and Bjerkvig, R. (2003). Oxygenation and response to irradiation of organotypic multicellular spheroids of human glioma. Anticancer Res. 23, 1461-1466.
75. Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G. J., Rogers, A. E., Traish, A. M. and Sonenshein, G. E. (1997). Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100, 2952-2960.
76. Spinardi, L., Einheber, S, Cullen, T., Milner, T. A. and Giancotti, F. G. (1995). A recombinant tail-less integrin beta 4 subunit disrupts hemidesmosomes, but does not suppress alpha 6 beta 4-mediated cell adhesion to laminins. J. Cell Biol. 129, 473-487.
77. St Croix, B., Florenes V. A., Rak, J. W., Flanagan, M., Bhattacharya, N., Slingerland, J. M. and Kerbel, R. S. (1996). Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents. Nat. Med. 2, 1204-1210.
78. Sutherland, R. M. and Durand, R. E. (1972). Radiosensitization by nifuroxime of the hypoxic cells in an in vitro tumour model. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 22, 613-618.
79. Tagliabue, E., Ghirelli, C., Squicciarini, P., Aiello, P., Colnaghi, M. I. and Menard, S. (1998). Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells. Clin. Cancer Res. 4, 407-410.
80. Tang, Y., Chen, Z., Ambrose, D., Liu, J., Gibbs, J. B., Chernoff, J. and Field, J. (1997). Kinase-deficient Pak1 mutants inhibit Ras transformation of Rat-1 fibroblasts. Mol. Cell. Biol. 17, 4454-4464.
81. Tang, Y., Yu, J. and Field, J. (1999). Signals from the Ras, Rac, and Rho GTPases converge on the Pak protein kinase in Rat-1 fibroblasts. Mol. Cell. Biol. 19, 1881-1891.
82. Tannock, I. F., Lee, C. M., Tunggal, J. K., Cowan, D. S. and Egorin, M. J. (2002). Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Clin. Cancer Res. 8, 878-884.
83. Taylor-Papadimitriou, J., D'Souza, B., Berdichevsky, F., Shearer, M., Martignone, S. and Alford, D. (1993). Human models for studying malignant progression in breast cancer. Eur J. Cancer Prev. 2 Suppl. 3, 77-83.
84. Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J. and Jain, R. K. (2004). Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res. 64, 3731-3736.
85. Unger, M. and Weaver, V. M. (2003). The tissue microenvironment as an epigenetic tumor modifier. Methods Mol. Biol. 223, 315-347.
86. Vadlamudi, R. K. and Kumar, R. (2003). P21-activated kinases in human cancer. Cancer Metastasis Rev. 22, 385-393.
87. Van Aelst, L. and D'Souza-Schorey, C. (1997). Rho GTPases and signaling networks. Genes Dev. 11, 2295-2322.
88. Vander Heiden, M. G., Plas, D. R., Rathmell, J. C., Fox, C. J., Harris, M. H. and Thompson, C. B. (2001). Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol. Cell. Biol. 21, 5899-5912.
89. Wang, R. A., Zhang, H., Balasenthil, S., Medina, D. and Kumar, R. (2006). PAK1 hyperactivation is sufficient for mammary gland tumor formation. Oncogene 25, 2931-2936.
90. Wan, W., Wyckoff, J. B., Frohlich, V. C., Oleynikov, Y., Huttelmaier, S., Zavadil, J., Cermak, L., Bottinger, E. P., Singer, R. H., White, J. G. et al. (2002). Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res. 62, 6278-6288.
91. Weaver, V. M., Petersen, O. W., Wang, F., Larabell, C. A., Briand, P., Damsky, C. and Bissell, M. J. (1997). Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137, 231-245.
92. Weaver, V. M., Lelievre, S., Lakins, J. N., Chrenek, M. A., Jones, J. C., Giancotti, F., Werb, Z. and Bissell, M. J. (2002). beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2, 205-216.
93. Whitacre, C. M. and Berger, N. A. (1997). Factors affecting topotecan-induced programmed cell death: adhesion protects cells from apoptosis and impairs cleavage of poly(ADP-ribose)polymerase. Cancer Res. 57, 2157-2163.
94. Yang, C., Liu, Y., Leskow, F. C., Weaver, V. M. and Kazanietz, M. G. (2005). RacGAP-dependent inhibition of breast cancer cell proliferation by [beta]2-chimerin. J. Biol. Chem. 280, 24363-24370.
95. Zahir, N. and Weaver, V. M. (2004). Death in the third dimension: apoptosis regulation and tissue architecture. Curr. Opin. Genet. Dev. 14, 71-80.
96. Zahir, N., Lakins, J. N., Russell, A., Ming, W., Chatterjee, C., Rozenberg, G. L, Marinkovich, M. P. and Weaver, V. M. (2003). Autocrine laminin-5 ligates alpha6beta4 integrin and activates RAC and NFkappaB to mediate anchorage-independent survival of mammary tumors. J. Cell Biol. 163, 1397-1407.
97. Zakeri, Z. and Lockshin, R. A. (2002). Cell death during development. J. Immunol. Methods 265, 3-20.